GL1X · GenesisL1 explorer

Research workbench

Structural basis for the inhibition of mycobacterium tuberculosis L,D- transpeptidase by meropenem, a drug effective against extensively drug-resistant strains

Analyse Structural basis for the inhibition of mycobacterium tuberculosis L,D… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4GSR
Type
protein
Length
263 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Probable conserved lipoprotein lpps
UniProt
O53223
Ligands
EMT
Pockets
2 · best druggability 0.51

Structure

x-ray diffraction · 1 distinct chain · 12% helix, 40% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProbable conserved lipoprotein lppsprotein26312% helix, 40% strandO53223

Ligands and binding sites

  • EMT · 2-(ethylmercuri-thio)-benzoic acid · ligand · chains A
  • GOL · Glycerol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11050.510.8224empty
2670.310.7412empty

Compared structures

  • 4GSR · Structural basis for the inhibition of Mycobacterium tuberculosis L,D-transpeptidase by… · the same entry in another collection · chain A against A, TM-score 1.00
  • O53223 · AlphaFold monomer V2.0 prediction for L,D-transpeptidase 2 (O53223) · a predicted model of the same protein · chain A against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.